Obstetrics Quick Reference – Key NCLEX Nursing Topics

Eclampsia

Eclampsia

Eclampsia is a serious and life-threatening complication of pregnancy characterized by the onset of seizures in a woman with preeclampsia (high blood pressure, protein in urine, and other signs of organ dysfunction). It usually occurs in the third trimester, during labor, or postpartum. Symptoms may include headache, visual disturbances, right upper abdominal pain, and sudden seizures. Eclampsia can lead to complications such as placental abruption, stroke, coma, and even maternal or fetal death. Immediate treatment involves magnesium sulfate to control seizures, blood pressure management, and often emergency delivery of the baby. Early detection and management of preeclampsia are key to preventing eclampsia.

1. Pathogenesis Triad

  1. Vasospasm → End-organ ischemia
  2. Endothelial Injury → Proteinuria/edema
  3. Cerebral Dysregulation → Seizures

Key Mechanism:

  • Imbalance in angiogenic (PlGF) vs anti-angiogenic (sFlt-1) factors

 

2. Risk Stratification (PRE-ECLAMP Mnemonic)

High Risk (5x↑)Moderate Risk (2x↑)
Prior eclampsiaNulliparity
Renal diseaseAge >40 or <18
Chronic hypertensionBMI >35
Multifetal gestationFamily history
APS/ThrombophiliaIVF pregnancy

 

3. Diagnostic Criteria

Required:

  • Seizures in pregnant/postpartum woman + ONE of:
    • BP ≥160/110 mmHg
    • Proteinuria ≥300mg/24h
    • End-organ dysfunction (Cr >1.1, ALT >40, platelets <100K)

Red Flags for Impending Seizure:

  • HEADACHE (Persistent, opioid-resistant)
  • VISION CHANGES (Scotomas, blurred vision)
  • EPIGASTRIC PAIN (Liver capsule distension)

 

4. Emergency Management

A. Acute Seizure Response (TIME-CRITICAL)

  1. Position: Left lateral to prevent aspiration
  2. Oxygen: 10L/min via non-rebreather
  3. Mag Sulfate:
    • Load: 6g IV over 15-20 min
    • Maintenance: 2g/hr IV (therapeutic level 4-7 mEq/L)
  4. BP Control:
    • 1st Line: Labetalol 20mg IV → 40mg → 80mg q10min (max 300mg)
    • 2nd Line: Hydralazine 5-10mg IV q20min

B. Delivery Decision

  • Category 1 C-section if:
    • Recurrent seizures despite MgSO₄
    • Non-reassuring fetal status
    • Maternal multiorgan failure

 

5. Monitoring Parameters

SystemAssessmentFrequency
NeurologicPatellar reflexes, RR (↓ if <12)Q1h
CardiovascularBP (target <160/110)Q15min acute phase
RenalUOP (>30mL/hr), CrQ4h
FetalContinuous CTGUntil delivery

MagSO₄ Toxicity Checklist:
Absent DTRs
 RR <12
 UOP <30mL/hr

 

6. Nursing Action Plan

A. Safety Measures

  • Bed in lowest position, padded rails
  • Airway kit at bedside

B. Fluid Management

  • Strict I/O (limit to 80mL/hr unless bleeding)
  • Watch for pulmonary edema (crackles, SpO₂ <94%)

C. Patient Education

  • "Report any new headache or visual changes"
  • "No sudden BP drops" (risk placental hypoperfusion)

 

7. Complications & Prognosis

Maternal Risks:

  • HELLP (15% of cases)
  • Postpartum stroke (BP lability x48h)

Fetal Risks:

  • Abruption (20%)
  • IUGR (30%)

Survival Rates:

  • Maternal mortality <1% with treatment
  • Perinatal mortality 5-10%

 

8. Prevention Strategy

High-Risk Patients:

  • Low-dose aspirin (81mg daily) starting at 12w
  • Calcium 1g/day if dietary intake low

Postpartum Monitoring:

  • BP checks q15min x2h → q1h x24h
  • MagSO₄ continued x24h postpartum

 

Clinical Pearls

  1. "MgSO₄ First": Antihypertensives should NEVER delay seizure prophylaxis
  2. No Phenytoin: Ineffective for eclamptic seizures
  3. Delivery Cure: Symptoms may worsen initially postpartum (48h critical window